abstract |
Methods of using compounds which are progesterone receptor agonists for contraception and the treatment of progesterone-related maladies alone or in combination with an estrogen receptor agonist or progesterone receptor antagonist are provided. These compounds have the structure: n nwherein R 1 , R 2 , R 3 , R 4 , R 5 , and Q 1 are defined herein. |